EGYPTIAN INTERNATIONAL PHARMACEUTICALS (EIPICO) financial statements, including revenue, expenses, profit, and loss

The total revenue of PHAR for the last quarter is 1.88 B EGP, and it's 25.01% higher compared to the previous quarter. The net income of Q2 24 is 175.57 M EGP.